NCT02351219View on ClinicalTrials.gov

FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Pancreatic Carcinoma Stage III
Interventions
DRUG

FOLFOXIRI

Trial Locations (1)

56126

Azienda Ospedaliero-Universitaria Pisana, Pisa

All Listed Sponsors
lead

Azienda Ospedaliero, Universitaria Pisana

OTHER

NCT02351219 - FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer | Biotech Hunter | Biotech Hunter